ns 1619 has been researched along with Blood Pressure, High in 2 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellien, J | 1 |
Favre, J | 1 |
Iacob, M | 1 |
Gao, J | 1 |
Thuillez, C | 1 |
Richard, V | 1 |
Joannidès, R | 1 |
Bratz, IN | 1 |
Falcon, R | 1 |
Partridge, LD | 1 |
Kanagy, NL | 1 |
1 trial available for ns 1619 and Blood Pressure, High
Article | Year |
---|---|
Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans.
Topics: Adult; Animals; Benzimidazoles; Biological Factors; Blood Pressure; Elasticity; Endothelium, Vascula | 2010 |
1 other study available for ns 1619 and Blood Pressure, High
Article | Year |
---|---|
Vascular smooth muscle cell membrane depolarization after NOS inhibition hypertension.
Topics: Animals; Arginine; Benzimidazoles; Calcium; Cell Membrane; Endothelium, Vascular; Enzyme Inhibitors; | 2002 |